First Human Ebola Vaccine Trial Shows It Seems to Work

[muriel_volestrangler]

Source: NBC

The first test of an Ebola vaccine in people shows it's safe and appears to be working as designed, doctors reported Wednesday.

A look at the first 20 people injected with the vaccine, which has been shown to protect monkeys from Ebola, shows no dangerous side effects. And it seems to be producing an immune response that would be expected to protect them from infection.

"This response is very comparable to the level of the response that actually protected the animals," said Dr. Tony Fauci, head of the National Institute for Allergy and Infectious Diseases, which helped develop and test the vaccine.
...
There's no ethical way to vaccinate people and then expose them to Ebola on purpose, of course, so the trial is designed to see if the vaccine is safe and if the immune system responds in a way that would be expected to protect them. It did, the NIAID researchers report in the New England Journal of Medicine.

Read more: http://www.nbcnews.com/storyline/ebola-virus-outbreak/first-human-ebola-vaccine-trial-shows-it-seems-work-n256196

[deurbano]

1. Good news! Thanks for sharing this.

[rocktivity]

2. There is also work being done on detecting Ebola during the incubation period

Last edited Thu Nov 27, 2014, 12:00 AM - Edit history (1)

http://yourhhrsnews.com/quick-cheap-ebola-tests-could-be-key-to-halting-virus

The Q16 can diagnose the virus within five days of infection...(Another) invention...dabs...blood...on a silicon chip and shines a single-colored LED through it. The Ebola-specific particles appear as bright dots on the chip...

A vaccine divided by a faster diagnosis plus an antidote equals buh-bye, Ebola!


rocktivity

[Omaha Steve]

3. K&R!

[drynberg]

4. So, which Big Pharma will land this big profit maker? Has this been decided already...wouldn't

Surprise me at all...and by keeping the tenants of the profit motive, this inoculation will be for wealthy folks only, ok?

[muriel_volestrangler]

5. As the article says, GSK (GlaxoSmithKline) is the co-developer of this vaccine

from before the current outbreak:

GSK acquired this Ebola vaccine candidate through the acquisition of a biotechnology company, Okairos, in May 2013 and has since been working with the US National Institutes of Health to develop this vaccine candidate in response to the threat of Ebola.

http://www.gsk.com/en-gb/our-stories/health-for-all/our-contribution-to-the-fight-against-ebola/

http://www.niaid.nih.gov/topics/ebolamarburg/research/pages/default.aspx

There isn't a 'big profit' in an Ebola vaccine, since 'wealthy folks' haven't been at risk. This would be like moaning about the 'big profit' in yellow fever vaccines.

And you mean 'tenets', not 'tenants'. If you're going to use clichés, at least spell them right.